Skip to main content
CDC Website

STDs

Bringing High-Quality HIV and STD Prevention to Youth in Schools: CDC's Division of Adolescent and School Health

Submitted by NPIN admin in on

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: schools play a critical role in HIV and STD prevention; prevention programs can reduce risk behaviors; DASH promotes effective prevention through schools; National HIV/AIDS Strategy; and Dash's programs are data driven and evidence based.

The Role of STD Prevention and Treatment in HIV Prevention

Submitted by NPIN admin in on

This information sheet discusses the link between STDs and HIV. It explains how individuals with STDS have an increased susceptibility to HIV and individuals with HIV have increased infectiousness. The information sheet discusses how STD treatment can slow the spread of HIV and the implications for HIV and STD prevention programs. Information is provided for accessing the services of national health organizations.

Effective HIV and STD Prevention Programs for Youth: A Summary of Scientific Evidence

Submitted by NPIN admin in on

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: Effective HIV/STD Prevention Education Programs; Youth Asset-Development Programs; CDC's Ongoing Efforts to Identify and Implement Effective HIV/STD Prevention Programs for Youth.

TB in those with HIV in French (Congo)

Submitted by NPIN admin in on

This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.

The Clinical Approach to the STD Patient

Submitted by NPIN admin in on

This monograph is a curricular outline for examination of an STD patient. It explains the rationale and general clinical approach including epidemiological and medical goals of an STD intervention, taking a sexual history, risk indicators for STD, chief complaint and history of present illness, past medical and STD history, gynecologic history, HIV risk assessment, social history, clinical management, and patient education.

MMWR: Neisseria Gonorrhoeae with Reduced Susceptibility to Azithromycin - San Diego County, California, 2009

Submitted by NPIN admin in on

This report summarizes laboratory and epidemiologic findings associated with reduced susceptibility to azithromycin. It notes that in August-October 2009, five of 55 N. gonorrhoeae isolates obtained from men with symptomatic urethritis tested at San Diego County’s main municipal STD clinic had high azithromycin minimum inhibitory concentrations (MIC)s.

CDC Grand Rounds: Chlamydia Prevention: Challenges and Strategies for Reducing Disease Burden and Sequelae

Submitted by NPIN admin in on

This report discusses the sexually transmitted disease (STD), chlamydia, which is common among sexually active adolescents and young adults. It explains that although chlamydia may be asymptomatic, it can have serious consequences in females, including infertility; hence, the importance of chlamydia prevention. Screening females aged <25 years is ranked by the National Commission on Prevention Priorities as one of the 10 most beneficial and cost-effective prevention services, but it also is one of the most underutilized.

Volume and Type of Laboratory Testing Methods for Sexually Transmitted Diseases in Public Health Laboratories 2007: Summary Report

Submitted by NPIN admin in on

This report provides a summary of responses from a web-based survey of public health laboratories on volume and type of testing for STDs in the United States in 2007. The survey was conducted in 2008. Responses were received from 61.4 percent (94 of 153) participants. In 2007, 3,290,390 chlamydia tests and 3,157,827 gonorrhea tests were performed in the surveyed laboratories; 89.7 percent of chlamydia tests and 84.4 percent of gonorrhea tests were nucleic acid amplification tests. Over 90 percent of responders reported syphilis testing.

MMWR: Discordant Results From Reverse Sequence Syphilis Screening - Five Laboratories, United States, 2006-2010

Submitted by NPIN admin in on

This report describes tests of an analysis of data from five laboratories that used reverse sequence screening during 2006-2010 to identify persons with possible untreated syphilis. Three sites served patient populations with low prevalence of syphilis, and two sites served patient population with high prevalence. The results indicated that among sera reactive on initial screening with an automatable treponemal enzyme and chemiluminescence immunoassays (EIA/CIA), 56.7 percent had a nonreactive rapid plasma regain (RPR) test.

Sifilis: La Realidad

Submitted by NPIN admin in on

This pamphlet provides information about the STD syphilis. It lists basic facts about the disease and discusses transmission, symptoms for men and women, testing, and treatment. The pamphlet explains that recent sex partners should be notified, as they would need to be tested for the disease and treated if infected. Syphilis can be cured with antibiotic treatment, but an individual can be reinfected.